Home Medicine Nanomedicine: visions, risk, potential
Article
Licensed
Unlicensed Requires Authentication

Nanomedicine: visions, risk, potential

  • Jan Mehlich and Felix Thiele EMAIL logo
Published/Copyright: March 6, 2014
Become an author with De Gruyter Brill

Abstract

In the field of medicine nanotechnology may help to develop new and effective applications. However, as with many modern technologies, there are considerable moral, legal and social concerns about the consequences nanotechnology may have for humans and their environment. More than in many other areas of nanotechnology, nanomedicine stimulates stakeholders to raise concerns. Not only are patients concerned, but so are those in politics and administration, in industry and in the scientific community there are substantial debates about ethical, legal, and social implications (ELSI) of nanomedicine.


Europäische Akademie Wilhelmstrasse 56, Bad Neuenahr-Ahrweiler 53474, Germany, E-mail:

  1. 1

    For further information see www.nanodiara.eu

  2. 2

    The winning poster was Jutta Jahnel’s (Karlsruhe Institute of Technology, Institute for Technology Assessment and System Analysis) contribution entitled “Challenges and questions in nanomedicine legislation”.

Article note: The paper reflects the authors’ opinions about the reported conference in particular and nanomedicine in general. The views presented here do not necessarily match with the views of the speakers at the conference.

Received: 2013-8-22
Accepted: 2014-2-11
Published Online: 2014-03-06
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 28.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ejnm-2013-0022/html
Scroll to top button